Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 0.155% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Cc1cc(NS(=O)(=O)c2ccc(NC(=S)NCc3ccccc3)cc2)no1
b: COc1ccccc1CCNC(=O)CCn1nc(C)c2c(C)n(-c3ccccc3)nc2c1=O
Answer: b. COc1ccccc1CCNC(=O)CCn1nc(C)c2c(C)n(-c3ccccc3)nc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1CCNC(=O)CCn1nc(C)c2c(C)n(-c3ccccc3)nc2c1=O
COc1ccccc1CCNC(=O)CCn1nc(C)c2c(C)n(-c3ccccc3)nc2c1=O
3-(3,4-dimethyl-7-oxo-2-phenylpyrazolo[3,4-d]pyridazin-6-yl)-N-[2-(2-methoxyphenyl)ethyl]propanamide